Company Filing History:
Years Active: 2019-2025
Title: Fredrik Öberg: Innovator in Cancer Treatment
Introduction
Fredrik Öberg is a notable inventor based in Huddinge, Sweden. He has made significant contributions to the field of cancer treatment, holding a total of 3 patents. His work focuses on innovative therapies that aim to improve patient outcomes in oncology.
Latest Patents
Öberg's latest patents include groundbreaking inventions such as a cancer treatment utilizing (2,2-bishydroxymethyl) methylenecyclopropane nucleotides. This invention provides a compound formula aimed at enhancing therapeutic efficacy. Another significant patent involves a combination therapy for liver cancer, which integrates sorafenib or regorafenib with a phosphoramidate prodrug of troxacitabine. This combination shows promising utility in treating liver cancer and liver metastasis, demonstrating Öberg's commitment to advancing cancer therapies.
Career Highlights
Throughout his career, Fredrik Öberg has worked with prominent companies in the pharmaceutical industry, including Medivir Aktiebolag and Medivir AB. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to the advancement of cancer treatment.
Collaborations
Öberg has collaborated with notable professionals in his field, including Björn Klasson and Mark Albertella. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work.
Conclusion
Fredrik Öberg's contributions to cancer treatment through his patents and collaborations highlight his role as an influential inventor in the medical field. His innovative approaches continue to pave the way for advancements in oncology.